What We Have
Explore Our Main Services
Orphaion is a specialized pharmaceutical representation company committed to bringing innovative, high-impact therapies—particularly orphan drugs—to patients in Greece and Eastern Europe.
Market Research & Analysis
As specialists in rare diseases, we provide strategic insights based on deep knowledge of the local market. We go beyond surface-level consulting to deliver a foundational understanding that supports sustainable growth strategies.
Read More
Market Access Strategy & Coordination
Navigating the complex regulatory environments of Greece and Cyprus demands local expertise.
Read More
Marketing Execution & Stakeholder Engagement
We support both pre- and post-marketing efforts through targeted campaigns and initiatives Read More
We are a specialized consultancy focused on Rare Diseases offering end-to-end support to biopharma partners from early access through commercialization. With a multidisciplinary team and deep local expertise, we are uniquely positioned to guide you through every challenge in this highly specialized field.
To advance access to life-changing therapies for patients with rare diseases by combining scientific excellence, ethical responsibility, and strategic insight.
- Integrity: We operate transparently and adhere to the highest ethical and scientific standards.
- Excellence: We commit to quality and continuous improvement in every project.
- Innovation: We embrace creativity and challenge the status quo to deliver better outcomes.
- Respect: We value the diverse experiences of our team, our partners, and the communities we serve.
- Equity: We ensure fair access to opportunities and always consider the impact of our work on vulnerable populations.
- Objectivity: We provide evidence-based solutions free from bias or external influence.
In Europe, a rare disease affects fewer than 1 in 2,000 people. While each condition is rare on its own, collectively rare diseases affect an estimated 30 million people across the EU. Most are chronic, life-threatening, and often genetically driven.
We are committed to improving the lives of people with rare diseases by enhancing diagnosis, access, and support. We work alongside healthcare providers, regulators, and advocacy groups to shorten diagnostic journeys, increase awareness, and create meaningful change for patients and their families.
We believe in the power of collaboration. Our partnerships span biotech innovators, academic institutions, and advocacy organizations. Together, we work to bring transformative therapies to market faster and more efficiently, always with patients at the center of our mission.
How We Engage with the Community
Our work is shaped by the people we serve. We actively engage with rare disease communities through education, advocacy support, and transparent dialogue. We amplify patient voices, address unmet needs, and help ensure that every strategic decision considers the lived experience of patients and caregivers.